MMP9 and ovarian carcinoma: The role of VEGF-VEGFR in invasion and migration of ovarian cancer is proven in vitro through the secretion and activation of Matrix Metalloproteinase-2 (MMP-2), MMP-7, MMP-9 and urokinase type plasminogen activators.